EBM Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Eastwood Bio-Medical Canada Inc

Watchlist Manager

Watchlist

Price: 1.83 CAD 1.1% Market Closed

Market Cap: CA$126.1m

	Eastwood Bio-Medical Canada Inc XTSX:EBM	CA
C	China Petroleum & Chemical Corp XHAM:CHU	CN

Profitability Summary

Eastwood Bio-Medical Canada Inc's profitability score is 33/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

73%

Strong 3Y Average Gross Margin

65%

Gross Margin is Increasing

64% > 73%

Negative Operating Margin

-27%

Negative 3Y Average Operating Margin

-59%

Operating Margin is Increasing

-36% > -27%

Negative Net Margin

-28%

Negative 3Y Average Net Margin

-60%

Net Margin is Increasing

-35% > -28%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

-3% > 0%

Positive ROE

14%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-190%

Declining ROIC

-108% > -193%

View All

Hide

Collapse

33 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.